Skip to content

SPAC Feed

Curated SPACs News

  • News
  • Opinions
  • Events
  • Videos
  • Resources
  • Contact Us
  • S-1 Filing
Posted on October 6, 2023

S-1/A – Aeglea BioTherapeutics, Inc. (0001636282) (Filer)

Filed: 2023-10-10 AccNo: 0001193125-23-252528 Size: 3 MB
Source: S-1/A – Aeglea BioTherapeutics, Inc. (0001636282) (Filer)

By sf-admin

Post navigation

Electric Vehicle Co. Faraday Inks $7.5M Shareholder Deal – Law360
$1 billion SWFL cancer services network begins trading on Nasdaq – Business Observer


  • About Us
  • Contact Us
  • Subscribe
Copyright © 2026 SPAC Feed. All Rights Reserved | News Vibe by Theme Palace